Challenges in VC, Drug Pricing, and Novo’s Wegovy Choice
TLDR: Novo Nordisk halted its expansion of Wegovy for heart failure The government is in drug pricing negotiation In the recent article by STAT, the authors discuss the abrupt decision by Novo